Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,872 | 170 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $511.22 | 26 | $0 (2023) |
| Abbott Laboratories | $319.59 | 17 | $0 (2024) |
| PFIZER INC. | $280.15 | 10 | $0 (2023) |
| Amgen Inc. | $257.63 | 13 | $0 (2023) |
| CONMED Corporation | $209.82 | 3 | $0 (2018) |
| ABBVIE INC. | $197.76 | 12 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $197.04 | 11 | $0 (2021) |
| Allergan, Inc. | $192.93 | 6 | $0 (2020) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $174.03 | 4 | $0 (2020) |
| Lilly USA, LLC | $173.43 | 12 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $309.46 | 12 | Abbott Laboratories ($121.27) |
| 2023 | $481.60 | 23 | Novo Nordisk Inc ($156.71) |
| 2022 | $421.58 | 24 | ABBVIE INC. ($75.15) |
| 2021 | $715.50 | 42 | Amgen Inc. ($165.40) |
| 2020 | $785.99 | 39 | Allergan, Inc. ($180.07) |
| 2019 | $203.18 | 13 | PFIZER INC. ($68.75) |
| 2018 | $768.80 | 14 | CONMED Corporation ($209.82) |
| 2017 | $185.41 | 3 | Boehringer Ingelheim Pharmaceuticals, Inc. ($144.70) |
All Payment Transactions
170 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/04/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $20.60 | General |
| Category: Diabetes Care | ||||||
| 11/13/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $19.74 | General |
| Category: Diabetes Care | ||||||
| 11/11/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $13.67 | General |
| Category: Diabetes | ||||||
| 09/09/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $19.25 | General |
| Category: Diabetes Care | ||||||
| 08/21/2024 | Edwards Lifesciences Corporation | — | Food and Beverage | In-kind items and services | $110.10 | General |
| 06/07/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $22.00 | General |
| Category: Diabetes Care | ||||||
| 05/30/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $14.04 | General |
| Category: Diabetes | ||||||
| 05/28/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.81 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/23/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $20.48 | General |
| Category: Diabetes Care | ||||||
| 04/22/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $14.04 | General |
| Category: Endocrinology | ||||||
| 03/26/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $19.20 | General |
| Category: Diabetes Care | ||||||
| 02/27/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $20.53 | General |
| Category: RESPIRATORY | ||||||
| 12/28/2023 | Abbott Laboratories | FREESTYLE LIBRE 2 (Device) | Food and Beverage | In-kind items and services | $19.53 | General |
| Category: Diabetes Care | ||||||
| 12/13/2023 | Abbott Laboratories | FREESTYLE LIBRE 2 (Device) | Food and Beverage | In-kind items and services | $17.97 | General |
| Category: Diabetes Care | ||||||
| 11/30/2023 | Abbott Laboratories | FREESTYLE LIBRE 2 (Device) | Food and Beverage | In-kind items and services | $17.18 | General |
| Category: Diabetes Care | ||||||
| 10/25/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.95 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/27/2023 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $16.86 | General |
| Category: Diabetes Care | ||||||
| 09/21/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $16.95 | General |
| Category: Cardio-renal | ||||||
| 09/19/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $12.99 | General |
| Category: Diabetes | ||||||
| 08/24/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $13.85 | General |
| Category: Diabetes | ||||||
| 08/08/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $21.27 | General |
| Category: Inflammation | ||||||
| 08/03/2023 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $16.98 | General |
| Category: Diabetes Care | ||||||
| 07/19/2023 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $14.94 | General |
| Category: ANTIBIOTIC | ||||||
| 07/13/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.14 | General |
| Category: Gastroenterology | ||||||
| 05/11/2023 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $125.00 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 1,282 | 2,654 | $363,395 | $195,040 |
| 2022 | 15 | 1,322 | 2,563 | $350,650 | $180,930 |
| 2021 | 12 | 1,156 | 2,530 | $334,895 | $172,518 |
| 2020 | 15 | 1,271 | 2,868 | $373,606 | $194,293 |
All Medicare Procedures & Services
55 procedure records from CMS Medicare Utilization — Page 2 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 15 | 21 | $210.00 | $62.37 | 29.7% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 261 | 1,120 | $123,200 | $63,762 | 51.8% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 140 | 159 | $39,490 | $25,098 | 63.6% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 166 | 220 | $52,670 | $23,793 | 45.2% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 175 | 264 | $31,670 | $21,569 | 68.1% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 208 | 452 | $45,230 | $13,705 | 30.3% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 93 | 125 | $18,710 | $10,484 | 56.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 40 | 65 | $8,775 | $6,529 | 74.4% |
| 99309 | Subsequent nursing facility visit, typically 25 minutes per day | Office | 2021 | 16 | 48 | $6,320 | $3,433 | 54.3% |
| 99308 | Subsequent nursing facility visit, typically 15 minutes per day | Office | 2021 | 13 | 26 | $3,160 | $1,419 | 44.9% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 20 | 22 | $3,080 | $1,253 | 40.7% |
| 99497 | Advance care planning by the physician or other qualified health care professional, first 30 minutes | Facility | 2021 | 13 | 13 | $1,230 | $805.48 | 65.5% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2021 | 11 | 16 | $1,360 | $667.84 | 49.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 279 | 1,299 | $142,880 | $74,588 | 52.2% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 146 | 166 | $41,480 | $26,880 | 64.8% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 162 | 214 | $51,360 | $23,723 | 46.2% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 139 | 229 | $27,480 | $19,040 | 69.3% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2020 | 205 | 446 | $44,630 | $14,049 | 31.5% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 98 | 121 | $18,110 | $10,278 | 56.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 79 | 131 | $17,685 | $10,116 | 57.2% |
| 99309 | Subsequent nursing facility visit, typically 25 minutes per day | Office | 2020 | 18 | 52 | $6,640 | $3,742 | 56.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Office | 2020 | 16 | 50 | $5,500 | $2,900 | 52.7% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 21 | 25 | $4,500 | $2,685 | 59.7% |
| G0180 | Physician certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians to affirm the initial implem | Office | 2020 | 32 | 45 | $3,825 | $1,854 | 48.5% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 14 | 14 | $2,940 | $1,433 | 48.8% |
About Dr. Sean Nochimson, D.O
Dr. Sean Nochimson, D.O is a Internal Medicine healthcare provider based in Lauderhill, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/19/2015. The National Provider Identifier (NPI) number assigned to this provider is 1396124780.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sean Nochimson, D.O has received a total of $3,872 in payments from pharmaceutical and medical device companies, with $309.46 received in 2024. These payments were reported across 170 transactions from 31 companies. The most common payment nature is "Food and Beverage" ($3,872).
As a Medicare-enrolled provider, Nochimson has provided services to 5,031 Medicare beneficiaries, totaling 10,615 services with total Medicare billing of $742,781. Data is available for 4 years (2020–2023), covering 55 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Lauderhill, FL
- Active Since 05/19/2015
- Last Updated 07/17/2018
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1396124780
Products in Payments
- UBRELVY (Drug) $303.59
- Ozempic (Drug) $293.97
- AirSeal (Device) $209.82
- XARELTO (Drug) $197.04
- Micra (Device) $163.22
- FREESTYLE LIBRE 3 (Device) $155.11
- Vascepa (Drug) $147.74
- Otezla (Drug) $143.42
- EUCRISA (Drug) $139.42
- FARXIGA (Drug) $132.84
- FREESTYLE LIBRE 2 (Device) $128.13
- Epclusa (Drug) $124.99
- Kerendia (Drug) $102.20
- JARDIANCE (Drug) $92.42
- Aimovig (Biological) $82.52
- XIFAXAN (Drug) $74.39
- Yupelri (Drug) $71.41
- MOUNJARO (Drug) $68.21
- TRELEGY ELLIPTA (Drug) $67.98
- EMGALITY (Drug) $47.76
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Lauderhill
Dr. Ross Nochimson, M.d, M.D
Internal Medicine — Payments: $10,283
Dr. Jessica Geller, M.d, M.D
Internal Medicine — Payments: $990.36
Herbert Slavin, Md, MD
Internal Medicine — Payments: $717.60
Dr. Daniel Leon Roumain, M.d, M.D
Internal Medicine — Payments: $610.80
Dr. John Wolf, M.d, M.D
Internal Medicine — Payments: $189.45
Natasha Cedeno, M.d, M.D
Internal Medicine — Payments: $47.29